Clinical Trial Update: A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ibandronate (Bonviva) for post-menopausal osteoporosis has completed its study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonviva (ibandronate) (ibandronate)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Postmenopausal Osteoporosis | Phase 4 | Status: COMPLETED